Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal).

@article{Usonis2003AntibodyTA,
  title={Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal).},
  author={Vytautas Usonis and Vytautas Bakasenas and R Valentelis and G Katiliene and D Vidzeniene and Christian Herzog},
  journal={Vaccine},
  year={2003},
  volume={21 31},
  pages={4588-92}
}
To evaluate the immunogenicity and tolerability of Epaxal in infants and children, 30 infants (aged 6-7 months) and 30 children (aged 5-7 years) received a single intramuscular dose of the aluminium-free virosomal hepatitis A virus (HAV) vaccine Epaxal and a booster dose after 12 months. Anti-HAV antibody titres were measured at baseline (before injection), at 1 and 12 months after primary vaccination, and 1 month after the booster vaccination. Sixteen evaluable infants had maternal anti-HAV… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Lipid-based antigen delivery systems

Journal of Pharmaceutical Investigation • 2016
View 2 Excerpts

Similar Papers

Loading similar papers…